Targeting the Gut Microbiota in Kidney Disease : The Future in Renal Nutrition and Metabolism
Copyright © 2023 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved..
There is increasing interest in the therapeutic potential of manipulating the gut microbiome of patients with chronic kidney disease (CKD). This is because there is a substantial deviation from a balanced gut microbiota profile in CKD, with many deleterious downstream effects. Nutritional interventions such as plant-based diets with reduced animal protein intake and the use of probiotics, prebiotics, and synbiotics may alter the microbiome. This article aims to briefly describe what is known about the gut microbiome in patients with CKD, factors contributing to gut dysbiosis, and outline important evidence gaps. Future potential therapies, including restoring the microbiota with food and microbiota-based and metabolomic-based therapies, are also discussed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation - 33(2023), 6S vom: 01. Nov., Seite S30-S39 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lambert, Kelly [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chronic kidney disease |
---|
Anmerkungen: |
Date Completed 27.11.2023 Date Revised 18.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1053/j.jrn.2022.12.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361306814 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM361306814 | ||
003 | DE-627 | ||
005 | 20240218231852.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1053/j.jrn.2022.12.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n1298.xml |
035 | |a (DE-627)NLM361306814 | ||
035 | |a (NLM)37632511 | ||
035 | |a (PII)S1051-2276(22)00213-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lambert, Kelly |e verfasserin |4 aut | |
245 | 1 | 0 | |a Targeting the Gut Microbiota in Kidney Disease |b The Future in Renal Nutrition and Metabolism |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.11.2023 | ||
500 | |a Date Revised 18.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved. | ||
520 | |a There is increasing interest in the therapeutic potential of manipulating the gut microbiome of patients with chronic kidney disease (CKD). This is because there is a substantial deviation from a balanced gut microbiota profile in CKD, with many deleterious downstream effects. Nutritional interventions such as plant-based diets with reduced animal protein intake and the use of probiotics, prebiotics, and synbiotics may alter the microbiome. This article aims to briefly describe what is known about the gut microbiome in patients with CKD, factors contributing to gut dysbiosis, and outline important evidence gaps. Future potential therapies, including restoring the microbiota with food and microbiota-based and metabolomic-based therapies, are also discussed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Gut microbiome | |
650 | 4 | |a chronic kidney disease | |
650 | 4 | |a diet | |
650 | 4 | |a end-stage kidney disease | |
650 | 4 | |a gastrointestinal | |
650 | 4 | |a gut microbiota | |
650 | 4 | |a kidney failure | |
650 | 4 | |a nutrition | |
650 | 4 | |a prebiotics | |
650 | 4 | |a probiotics | |
650 | 4 | |a synbiotics | |
650 | 7 | |a Prebiotics |2 NLM | |
700 | 1 | |a Rinninella, Emanuele |e verfasserin |4 aut | |
700 | 1 | |a Biruete, Annabel |e verfasserin |4 aut | |
700 | 1 | |a Sumida, Keiichi |e verfasserin |4 aut | |
700 | 1 | |a Stanford, Jordan |e verfasserin |4 aut | |
700 | 1 | |a Raoul, Pauline |e verfasserin |4 aut | |
700 | 1 | |a Mele, Maria Cristina |e verfasserin |4 aut | |
700 | 1 | |a Wang, Angela Yee-Moon |e verfasserin |4 aut | |
700 | 1 | |a Mafra, Denise |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation |d 1997 |g 33(2023), 6S vom: 01. Nov., Seite S30-S39 |w (DE-627)NLM090689658 |x 1532-8503 |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2023 |g number:6S |g day:01 |g month:11 |g pages:S30-S39 |
856 | 4 | 0 | |u http://dx.doi.org/10.1053/j.jrn.2022.12.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 33 |j 2023 |e 6S |b 01 |c 11 |h S30-S39 |